Quarter Period Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7296920

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Quarter period statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
36,899,000 JPY
40,249,000 JPY
Operating profit (loss)
-916,306,000 JPY
-593,450,000 JPY
Non-operating income
Interest income
76,000 JPY
6,000 JPY
Non-operating income
409,000 JPY
8,000 JPY
Non-operating expenses
Non-operating expenses
JPY
5,594,000 JPY
Ordinary profit (loss)
-915,896,000 JPY
-599,036,000 JPY
Profit (loss) before income taxes
-915,896,000 JPY
-599,036,000 JPY
Income taxes - current
1,251,000 JPY
1,251,000 JPY
Income taxes
1,251,000 JPY
1,251,000 JPY
Profit (loss)
-917,147,000 JPY
-600,287,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.